Epidemiological and clinical factors impact on the benefit of riluzole in the survival rates of patients with ALS

Epidemiological and clinical factors impact on the benefit of riluzole in the survival rates of patients with ALS

ABSTRACT Objective To investigate the impact of epidemiological and clinical factors on the benefit of riluzole in patients with amyotrophic lateral sclerosis (ALS). Methods The survival rate of 578 patients with ALS (1999-2011) was analyzed by descriptive statistics and Kaplan-Meier curves. Con...

Full description

Bibliographic Details
Main Authors: Francis Meire Fávero, Mariana Callil Voos, Isac de Castro, Fátima Aparecida Caromano, Acary Souza Bulle Oliveira
Format: Article
Language:English
Published: Academia Brasileira de Neurologia (ABNEURO)
Series:Arquivos de Neuro-Psiquiatria
Subjects:
epidemiology
amyotrophic lateral sclerosis
motor neuron disease
survival
riluzole
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2017000800515&lng=en&tlng=en

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2017000800515&lng=en&tlng=en

Similar Items